NHS expands life-saving prostate cancer drug in England
The NHS in England will now offer abiraterone to 8,000 newly diagnosed men annually, a move hailed as 'momentous' that could halve deaths in this group and save over 3,000 lives in five years.
The NHS in England will now offer abiraterone to 8,000 newly diagnosed men annually, a move hailed as 'momentous' that could halve deaths in this group and save over 3,000 lives in five years.